8-K: Herbalife Reports Q1 2026 Growth, Exceeds Guidance

Herbalife Ltd. announced first quarter 2026 financial results, reporting net sales growth and adjusted EBITDA above guidance, and raising full-year outlook.

Summary

• Herbalife reported first quarter 2026 net sales of $1.3 billion, a 7.8% increase year-over-year (5.4% on a constant currency basis), exceeding guidance.
• Net income attributable to Herbalife was $61.9 million, with adjusted net income of $69.0 million.
• Adjusted EBITDA was $175.7 million, exceeding guidance, with adjusted EBITDA at constant currency of $180.3 million also exceeding guidance.
• Diluted EPS was $0.57, and adjusted diluted EPS was $0.64.
• Net cash provided by operating activities was $113.8 million.
• The company completed a $1.45 billion senior secured debt refinancing on April 29, 2026, expected to save approximately $45 million annually in cash interest.
• Herbalife acquired substantially all of the assets of Bioniq's core personalized nutrition business for $55 million on April 30, 2026.
• Full-year 2026 guidance for net sales and adjusted EBITDA has been revised upwards in the constant currency midpoint.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with the company exceeding key financial guidance metrics and successfully executing a significant debt refinancing and a strategic acquisition.

Positives

• Net sales growth of 7.8% year-over-year ($1.3 billion) exceeded guidance.
• Constant currency net sales growth of 5.4% exceeded guidance.
• Adjusted EBITDA of $175.7 million exceeded guidance.
• Constant currency adjusted EBITDA of $180.3 million exceeded guidance.
• Completion of a $1.45 billion senior secured debt refinancing is expected to result in approximately $45 million in annual cash interest savings.
• Acquisition of Bioniq's personalized nutrition business expands product offerings in a key growth area.
• Total leverage ratio decreased to 2.7x and net leverage ratio decreased to 2.1x.
• Raised full-year 2026 constant currency net sales and adjusted EBITDA guidance midpoints.

Negatives

• Gross profit margin decreased slightly to 77.9% from 78.3% in the prior year period, primarily due to input cost inflation and unfavorable sales mix.
• Adjusted EBITDA margin was 13.3%, down 20 basis points versus the first quarter of 2025, due to FX headwinds.
• Diluted EPS of $0.57 was lower than adjusted diluted EPS of $0.64.
• Net sales in North America declined 2.7% year-over-year.
• Net sales in EMEA declined 6.5% on a constant currency basis.
• Net sales in China declined 12.0% year-over-year (16.2% on a constant currency basis).

Risks

• Potential impacts of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs.
• Ability to attract and retain Members.
• Noncompliance with, or improper action by employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations.
• Adverse publicity associated with the Company or the direct-selling industry.
• Changing consumer preferences and demands and evolving industry standards.
• Legal and regulatory matters, including regulatory actions concerning, or legal challenges to, products or network marketing program and product liability claims.
• Risks associated with operating internationally and in China.
• Potential disruption to business caused by natural disasters, other catastrophic events, acts of war or terrorism, cybersecurity incidents, pandemics, and/or other acts by third parties.

Future Outlook

The company provided guidance for the second quarter of 2026, projecting net sales growth of +1.5% to +5.5% year-over-year (reported) and +1.0% to +5.0% (constant currency). Adjusted EBITDA guidance for Q2 is $150-$170 million. Full-year 2026 guidance has been revised, with narrowed ranges for net sales and adjusted EBITDA, and increased constant currency midpoints. Capital expenditures are reaffirmed at $50-$80 million for the full year.

Management Comments

• "We delivered net sales growth and adjusted EBITDA above our guidance for the quarter," said Chief Financial Officer John DeSimone.
• "We were also pleased to complete our $1.45 billion senior secured debt refinancing in April, achieving our pricing objectives, meaningfully reducing interest expense, extending our maturity profile, and further strengthening our balance sheet and financial flexibility."
• "Personalization has long been foundational to Herbalife's business, and our history is defined by innovation, a forward-looking mindset and a willingness to evolve alongside consumer needs," said Chief Executive Officer Stephan Gratziani.
• "Our recent acquisitions of Pro2col, Link BioSciences, Pruvit and Bioniq expand our personalization ecosystem, enabling an enhanced and differentiated experience for both customers and distributors and accelerating our evolution into the worlds premier health and wellness company, community and platform."

Industry Context

StockSavvy.ai notes that Herbalife's results and strategic acquisitions align with the broader industry trend towards personalized nutrition and health & wellness solutions. The company's focus on expanding its personalization ecosystem through acquisitions like Bioniq demonstrates a proactive approach to capturing market share in this growing segment.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact from exceeding financial guidance, debt refinancing leading to potential interest savings, and strategic acquisition aimed at future growth.
• Distributors: Potential for expanded product offerings through the Bioniq acquisition, and continued support through events like Herbalife Honors and Extravaganzas.
• Customers: Access to a broader range of personalized nutritional supplements and a refreshed product packaging design emphasizing science and nutrition.
• Creditors: Strengthened balance sheet and financial flexibility due to debt refinancing.

Next Steps

• Rollout of new packaging across the global product portfolio, which began in March 2026.
• Integration of Bioniq's personalized nutritional supplements into Herbalife's distribution channels, starting in Europe in late June 2026, followed by the United States in July 2026.
• Continued evolution into the world's premier health and wellness company, community, and platform.

Key Dates

Recommendation

While the company exceeded Q1 guidance and successfully refinanced debt, the mixed regional sales performance (declines in North America, EMEA, and China) and ongoing risks associated with the direct-selling industry and regulatory environment warrant a cautious approach. The strategic acquisition is positive but its full impact remains to be seen. Therefore, a 'hold' recommendation is appropriate pending further evidence of sustained growth across all key markets and successful integration of new acquisitions.

Keywords

Herbalife, Nutrition, Financial Results, Q1 2026, Adjusted EBITDA, Net Sales, Debt Refinancing, Acquisition